Navigation Links
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
Date:2/25/2008

They're at risk for new blockages within 3 years, study finds

MONDAY, Feb. 25 (HealthDay News) -- People who develop a blood clot in their legs (deep vein thrombosis) or in their lungs (pulmonary embolism) are at risk of developing another blood clot within three years, a new study suggests.

Deep vein thrombosis and pulmonary embolism are known collectively as venous thromboembolism.

Researchers looked at 1,691 people, average age 65, in Worcester, Mass., diagnosed with pulmonary embolism (549) and isolated deep vein thrombosis (1,142) in 1999, 2001 or 2003. During the three-year study, 31 (5.7 percent) of the pulmonary embolism patients had a recurrent clot in the lung, 75 (13.7 percent) had a recurrence of either type of venous thromboemolism, and 82 (14.9 percent) had a major bleeding episode (one that required blood transfusion).

Among the 1,142 patients with isolated deep vein thrombosis, 64 (5.6 percent) developed a pulmonary embolism, 217 (19 percent) had recurrent venous thromboembolism, and 146 (12.8 percent) had a major bleeding episode.

Patients with pulmonary embolism were more likely than those with deep vein thrombosis to die after one month (13 percent vs. 5.4 percent), one year (26 percent vs. 20.3 percent), and three years (35.3 percent vs. 29.6 percent).

"Patients whose course was complicated by major bleeding were more likely to experience recurrent venous thromboemolism or to die at three years than those without these complications," wrote Dr. Frederick A. Spencer, of McMaster University Medical Center in Hamilton, Ontario, Canada.

"Patients who presented with pulmonary embolism had similar rates of subsequent pulmonary embolism or recurrent venous thrombosis compared with patients with isolated deep vein thrombosis," the study authors noted.

"However, rates of recurrent venous thromboembolism and major bleeding after deep vein thrombosis and pulmonary embolism remain unacceptably high in the community setting. Efforts are needed to identify patients most at risk for venous thrombosis-associated complications and to develop better anti-coagulation strategies conducive to long-term use in the community setting," they concluded.

The study was published in the Feb. 25 issue of the Archives of Internal Medicine.

More information

The U.S. National Heart, Lung, and Blood Institute has more about deep vein thrombosis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Feb. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mechanism of blood clot elasticity revealed in high definition
2. Indiana Blood Center Signs BIO-key(R) Contract
3. Current Blood Sugar Control Test Results Inaccurate
4. Another way to grow blood vessels
5. Study identifies another strategy for normalizing tumor blood supply
6. Standard test for blood sugar control not accurate in diabetic dialysis patients
7. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
8. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
9. Blood pressure drug may have added benefit
10. Two Laptop Computers Missing From Lifebloods Main Office
11. Airplane Noise Boosts Blood Pressure Even During Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
(Date:7/28/2017)... ... July 28, 2017 , ... Lundquist Insurance Services, a family ... and families across east Texas, is embarking on a charity event in conjunction ... area. , America’s Mighty Warriors offers a series of programs for veterans that ...
(Date:7/28/2017)... ... 2017 , ... Leyden Insurance Agency, a Chicago based firm that offers asset ... County, is working in conjunction with the Conner T. Lowry Memorial Fund in a ... of a brave soldier who is still dearly missed by his community, the Connor ...
(Date:7/27/2017)... ... 2017 , ... Conventus, New Jersey’s premier professional liability insurer ... new educational series of webinars and podcasts to guide medical practices on understanding ... The first two episodes of the series, entitled “Pain Management and Opioids: New ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... Diplomate of the American Board of Oral Implantology/Implant Dentistry (ABOI/ID). After successfully completing ... the nation’s leading providers of dental implants . Dr. Kimowitz and his ...
(Date:7/27/2017)... ... ... Standard Process is ushering in a new era of innovation with the ... (NCRC) in Kannapolis, North Carolina and by announcing a new leadership team, board and ... occupying over 10,000 square feet on the first floor of the David H. Murdock ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... Aesthetics, a leading medical aesthetic clinic in Singapore ... skin conditions from the inside. The natural process of ... skin becomes more transparent due to the thinning of the epidermis. Over ... the sun contributes to aging skin, causing age spots and other ... ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/24/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... operating results on Monday, August 7, 2017 after market ... p.m. ET. Shareholders ... of the conference call by dialing 877-201-0168 or 647-788-4901 ... 15 minutes prior to the call. A live webcast ...
Breaking Medicine Technology: